Clinical Trial Management Systems (CTMS) Market – Global Trends, Opportunities,Challenges & Forecasts (2011 – 2016)


Total Pages - 240

TABLE OF CONTENTS

1	INTRODUCTION	
	1.1	KEY TAKE-AWAYS	
	1.2	REPORT DESCRIPTION	
	1.3	MARKETS COVERED	
	1.4	STAKEHOLDERS	
	1.5	RESEARCH METHODOLOGY	
	1.5.1	MARKET SIZE	
	1.5.2	ASSUMPTIONS MADE FOR THE REPORT	
	
2	SUMMARY	
	
3	MARKET OVERVIEW	
	3.1	INTRODUCTION	
	3.1.1	CLINICAL TRIAL DEFINITION	
	3.1.2	CLINICAL TRIAL PROCESS	
	3.1.3	CLINICAL TRIAL MANAGEMENT SYSTEM DEFINITION	
	3.2	ECLINICAL PROCESS & ECLINICAL PLATFORM	
	3.3	MARKET DYNAMICS	
	3.3.1	DRIVERS	
	3.3.1.1	Introduction	
	3.3.1.2	Ensures patient safety	
	3.3.1.3	Mitigates costs and offers competitive advantage	
	3.3.1.4	Secured anytime, anywhere access of web-based and cloud-based CTMS offerings	
	3.3.1.5	CTMS Integration with other Hospital Information Systems (HIS)	
	3.3.2	RESTRAINTS	
	3.3.2.1	Lack of awareness of CTMS in the research community	
	3.3.2.2	High cost of the system restricts the user count	
	3.3.2.3	Flexibility issues are more with on-premise CTMS model	
	3.3.3	OPPORTUNITIES	
	3.3.3.1	Shift of clinical trials and resources from AMCs to CROs in the past decade	
	3.3.3.2	Increasing clinical trial Outsourcing trend form Asian countries	
	3.3.4	MARKET SHARE ANALYSIS, BY COMPETITOR	
	
4	BENEFITS OF CTMS (KEY NEEDS AND BENEFITS INFLUENCING PURCHASING DECISIONS)	
	4.1	IMPROVED CLINICAL TRIAL EFFICIENCY WITH OPTIMIZED PROCESS & CENTRALIZED DATABASE	
	4.2	IMPROVES SITE PERFORMANCE BY ENHANCED INVESTIGATOR RELATIONSHIPS	
	4.3	HIGHER SUBJECT ACCRUAL RATE & REDUCED WORKLOAD FOR RESEARCH COORDINATORS	
	4.4	EFFECTIVELY MANAGE THE BUDGETING & BILLING ACTIVITES ASSOCIATED WITH CLINICAL TRIALS	
	4.5	IMPROVED COST EFFICIENCIES THROUGH REDUCED DATA ENTRY AT MULTIPLE SITE & MANUAL LABOR COSTS	
	4.6	IMPROVED CLINICAL RESEARCH ASSOCIATE PRODUCTIVITY	
	4.7	AUTOMATED DATA PROCESSING & REPORT GENERATING	
	
5	CHALLENGES/LIMITATIONS/UNMET NEEDS	
	5.1	EVOLUTION OF CTMS SYSTEM IN A TIMELY MANNER TO IMPROVE THE BUSINESS PROCESS	
	5.2	INTEROPERABILITY & INTEGRATION ISSUES	
	5.3	EXTENSIBILITY	
	5.4	SKEPTICISM IN USAGE & APPLICATIONS	
	5.5	COST & DURATION OF DEPLOYMENT	
	
6	COMPONENTS OF A CTMS (DRIVERS INFLUENCING THE BUYING PATTERN)	
	6.1	INTRODUCTION	
	6.2	PROTOCOL DESIGN & STUDY START UP	
	6.3	PATIENT & INVESTIGATOR RECRUITMENT	
	6.4	FINANCIAL MANAGEMENT & BILLING SOLUTIONS	
	6.5	CLINICAL DATA TRACKING & DATA ANALYSIS MODULE (PATIENT DATA MANAGEMENT & SITE MANAGEMENT)	
	6.6	DOCUMENT MANAGEMENT SYSTEM (REGULATORY DOCUMENT MANAGEMENT & PROGRESS REPORTS)	
	6.7	CLINICAL SUPPLIES MANAGEMENT	
	6.8	ADVERSE EVENTS (AE) & SERIOUS ADVERSE EVENTS (SAE) MANAGEMENT	
	6.9	CENTRAL DOCUMENT REPOSITORY	
	
7	MARKET BY END-USER (TARGET MARKET FOR CTMS)	
	7.1	INTRODUCTION	
	7.2	CLINICAL RESEARCH ORGANIZATIONS (CROS) CTMS MARKET	
	7.3	PHARMACEUTICAL CTMS MARKET	
	7.4	HEALTHCARE PROVIDERS CTMS MARKET	
	
8	MARKET BY DELIVERY MODE	
	8.1	INTRODUCTION	
	8.2	WEB-BASED (HOSTED) CTMS	
	8.3	LICENSED ENTERPRISE (ON PREMISE) CTMS	
	8.4	CLOUD-BASED (SAAS) CTMS	
	
9	MARKET BY COMPONENTS	
	9.1	INTRODUCTION	
	9.2	SOFTWARE	
	9.3	HARDWARE	
	9.4	SERVICES	
	
10	MARKET BY CTMS TYPE	
	10.1	INTRODUCTION	
	10.2	ENTERPRISE CTMS	
	10.3	SITE CTMS	
	
11	CTMS PENETRATION	
	
12	GEOGRAPHICAL ANALYSIS	
	12.1	INTRODUCTION	
	12.2	NORTH AMERICA	
	12.2.1	U.S.	
	12.2.2	CANADA	
	12.3	EUROPE	
	12.4	ASIA	
	12.5	REST OF THE WORLD (ROW)	
	
13	CLINICAL TRIALS	
	13.1	INTRODUCTION	
	13.2	MARKET DYNAMICS FOR CLINICAL TRIALS	
	13.2.1	DRIVERS	
	13.2.1.1	Globalizing drug development activities	
	13.2.1.2	Rise in R&D investments expected to boost the clinical trials market	
	13.2.1.3	High disease prevalence in emerging countries	
	13.2.2	RESTRAINT	
	13.2.2.1	Longer approval time for clinical trials – A cause of concern for major pharmaceutical/ biopharmaceutical players	
	13.2.3	BURNING ISSUES	
	13.2.3.1	Out skirting boundaries of medical ethics	
	13.2.4	WINNING IMPERATIVE	
	13.2.4.1	Leveraging online resources to increase patient recruitment rates in clinical trials	
	13.3	CLINICAL TRIAL OUTSOURCING & ROLE OF ACADEMIC RESEARCH ORGANIZATIONS & CONTRACT RESEARCH ORGANIZATIONS	
	13.3.1	TRADITIONAL ROLE OF ACADEMIC RESEARCH CENTERS IN CONDUCTING CLINICAL TRIALS	
	13.3.2	TRADITIONAL ROLE OF CROS IN CONDUCTING CLINICAL TRIALS	
	13.3.3	EVOLVING ROLE OF ACADEMIC RESEARCH CENTERS IN CONDUCTING CLINICAL TRIALS	
	13.3.3.1	Following are considered as the Key reasons for loss of Market share of AMCs in Clinical trials	
	13.3.3.1.1	Proliferation of global trials	
	13.3.3.1.2	Clinical trial duration	
	13.3.3.1.3	Lack of Self financing capability	
	13.3.3.1.4	Development of In-house CROs of Pharmaceutical companies	
	13.3.3.1.5	Increasing clinical trial costs	
	13.3.4	EVOLVING ROLE OF CROS IN CONDUCTING CLINICAL TRIALS	
	13.3.4.1	Full service model	
	13.3.4.2	Hourly billing model	
	13.3.4.3	Full time equivalent model (FTE)	
	13.3.4.4	Fixed price model	
	13.4	CLINICAL TRIALS BY PLAYERS	
	13.4.1	BY INDUSTRY (CRO, NPO, PHARMACEUTICAL INDUSTRY)	
	13.4.2	BY INDUSTRY + HEALTHCARE PROVIDERS	
	13.4.3	BY OTHERS (U.S. FEDERAL ADMINISTRATION & NIH, OTHERS)	
	
14	COMPETITIVE LANDSCAPE	
	14.1	INTRODUCTION	
	14.2	COMPETITIVE DEVELOPMENTS	
	14.2.1	MERGERS & ACQUISITIONS	
	14.2.2	COLLABORATIONS/PARTNERSHIPS/AGREEMENTS/ CONTRACTS	
	14.2.3	NEW PRODUCTS LAUNCH	
	14.2.4	EXPANSIONS/NEW FACILITY/INVESTMENTS	
	14.2.5	OTHERS/FDA APPROVALS/GOVERNMENT GRANTS	
	
15	COMPANY PROFILES	
	15.1	ARIS GLOBAL LLC	
	15.1.1	OVERVIEW	
	15.1.2	FINANCIALS	
	15.1.3	PRODUCTS & SERVICES	
	15.1.4	STRATEGY	
	15.1.5	DEVELOPMENTS	
	15.2	BIOCLINICA INC.	
	15.2.1	OVERVIEW	
	15.2.2	FINANCIALS	
	15.2.3	PRODUCTS & SERVICES	
	15.2.4	STRATEGY	
	15.2.5	DEVELOPMENTS	
	15.3	BIO-OPTRONICS INC.	
	15.3.1	OVERVIEW	
	15.3.2	FINANCIALS	
	15.3.3	PRODUCTS & SERVICES	
	15.3.4	STRATEGY	
	15.3.5	DEVELOPMENTS	
	15.4	BUSINESS SYSTEMS INTEGRATION AG	
	15.4.1	OVERVIEW	
	15.4.2	FINANCIALS	
	15.4.3	PRODUCTS & SERVICES	
	15.4.4	STRATEGY	
	15.4.5	DEVELOPMENTS	
	15.5	DIGIPORT HOLDINGS PRIVATE LTD	
	15.5.1	OVERVIEW	
	15.5.2	FINANCIALS	
	15.5.3	PRODUCTS & SERVICES	
	15.5.4	STRATEGY	
	15.5.5	DEVELOPMENTS	
	15.6	DSG INC.	
	15.6.1	OVERVIEW	
	15.6.2	FINANCIALS	
	15.6.3	PRODUCTS & SERVICES	
	15.6.4	STRATEGY	
	15.6.5	DEVELOPMENTS	
	15.7	ERESEARCH TECHNOLOGY INC. (ERT)	
	15.7.1	OVERVIEW	
	15.7.2	FINANCIALS	
	15.7.3	PRODUCTS & SERVICES	
	15.7.4	STRATEGY	
	15.7.5	DEVELOPMENTS	
	15.8	FORTE RESEARCH SYSTEMS	
	15.8.1	OVERVIEW	
	15.8.2	FINANCIALS	
	15.8.3	PRODUCTS & SERVICES	
	15.8.4	STRATEGY	
	15.8.5	DEVELOPMENTS	
	15.9	GOBALTO	
	15.9.1	OVERVIEW	
	15.9.2	FINANCIALS	
	15.9.3	PRODUCTS & SERVICES	
	15.9.4	STRATEGY	
	15.9.5	DEVELOPMENTS	
	15.10	INNOVOCOMMERCE LLC	
	15.10.1	OVERVIEW	
	15.10.2	FINANCIALS	
	15.10.3	PRODUCTS & SERVICES	
	15.10.4	STRATEGY	
	15.10.5	DEVELOPMENTS	
	15.11	INTEGRATED CLINICAL SOLUTIONS INC.	
	15.11.1	OVERVIEW	
	15.11.2	FINANCIALS	
	15.11.3	PRODUCTS & SERVICES	
	15.11.4	STRATEGY	
	15.11.5	DEVELOPMENT	
	15.12	MEDIDATA SOLUTIONS	
	15.12.1	OVERVIEW	
	15.12.2	FINANCIALS	
	15.12.3	PRODUCTS & SERVICES	
	15.12.4	STRATEGY	
	15.12.5	DEVELOPMENTS	
	15.13	MEDNET SOLUTIONS	
	15.13.1	OVERVIEW	
	15.13.2	FINANCIALS	
	15.13.3	PRODUCTS & SERVICES	
	15.13.4	STRATEGY	
	15.13.5	DEVELOPMENTS	
	15.14	MERGE HEALTHCARE INCORPORATED	
	15.14.1	OVERVIEW	
	15.14.2	FINANCIALS	
	15.14.3	PRODUCTS & SERVICES	
	15.14.4	STRATEGY	
	15.14.5	DEVELOPMENTS	
	15.15	NEXTRIALS INC.	
	15.15.1	OVERVIEW	
	15.15.2	FINANCIALS	
	15.15.3	PRODUCTS & SERVICES	
	15.15.4	STRATEGY	
	15.15.5	DEVELOPMENTS	
	15.16	OMNICOMM SYSTEMS INC.	
	15.16.1	OVERVIEW	
	15.16.2	FINANCIALS	
	15.16.3	PRODUCTS & SERVICES	
	15.16.4	STRATEGY	
	15.16.5	DEVELOPMENTS	
	15.17	ORACLE CORPORATION	
	15.17.1	OVERVIEW	
	15.17.2	FINANCIALS	
	15.17.3	PRODUCTS & SERVICES	
	15.17.4	STRATEGY	
	15.17.5	DEVELOPMENTS	
	15.18	ORIAM	
	15.18.1	OVERVIEW	
	15.18.2	FINANCIALS	
	15.18.3	PRODUCTS & SERVICES	
	15.18.4	STRATEGY	
	15.18.5	DEVELOPMENTS	
	15.19	PAREXEL INTERNATIONAL CORPORATION	
	15.19.1	OVERVIEW	
	15.19.2	FINANCIALS	
	15.19.3	PRODUCTS & SERVICES	
	15.19.4	STRATEGY	
	15.19.5	DEVELOPMENTS	
	15.20	SPARTA SYSTEMS INC.	
	15.20.1	OVERVIEW	
	15.20.2	FINANCIALS	
	15.20.3	PRODUCTS & SERVICES	
	15.20.4	STRATEGY	
	15.20.5	DEVELOPMENTS	
	15.21	STUDYMANAGER INC.	
	15.21.1	OVERVIEW	
	15.21.2	FINANCIALS	
	15.21.3	PRODUCTS & SERVICES	
	15.21.4	STRATEGY	
	15.21.5	DEVELOPMENTS	
	15.22	TRIAL BY FIRE SOLUTIONS	
	15.22.1	OVERVIEW	
	15.22.2	FINANCIALS	
	15.22.3	PRODUCTS & SERVICES	
	15.22.4	STRATEGY	
	15.22.5	DEVELOPMENTS	
	15.23	OTHERS	
	15.23.1	ECLINFORCE INC.	
	15.23.1.1	Overview	
	15.23.1.2	Financials	
	15.23.1.3	Products & services	
	15.23.1.4	Strategy	
	15.23.2	VOLODYNE TECHNOLOGIES	
	15.23.2.1	Overview	
	15.23.2.2	Financials	
	15.23.2.3	Products & services	
	15.23.2.4	Strategy	
	15.23.3	DATABEAN LLC	
	15.23.3.1	Overview	
	15.23.3.2	Financials	
	15.23.3.3	Products & services	
	15.23.3.4	Strategy	
	15.23.4	CLINTRIAL WORKS	
	15.23.4.1	Overview	
	15.23.4.2	Financials	
	15.23.4.3	Products & services	
	15.23.4.4	Strategy	
			

LIST OF TABLES		
			
	TABLE 1		CTMS MARKET SIZE, BY GEOGRAPHY, 2008 – 2016 (MILLION)	
	TABLE 2		GLOBAL CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)	
	TABLE 3		CRO CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 4		NORTH AMERICA: CRO CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)		
	TABLE 5		PHARMACEUTICAL CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)		
	TABLE 6		NORTH AMERICA: PHARMACEUTICAL CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)		
	TABLE 7		PROVIDER CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 8		NORTH AMERICA: PROVIDER CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)	
	TABLE 9		CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)	
	TABLE 10	WEB-BASED CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 11	NORTH AMERICA: WEB-BASED CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)	
	TABLE 12	ON-PREMISE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 13	NORTH AMERICA: ON-PREMISE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)	
	TABLE 14	CLOUD-BASED CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 15	NORTH AMERICA: CLOUD-BASED CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)		
	TABLE 16	CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)	
	TABLE 17	SOFTWARE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 18	NORTH AMERICA: SOFTWARE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)	
	TABLE 19	HARDWARE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 20	NORTH AMERICA: HARDWARE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)	
	TABLE 21	SERVICES CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 22	NORTH AMERICA: SERVICES CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)	
	TABLE 23	CTMS MARKET REVENUE, BY TYPES, 2008 – 2016 ($MILLION)	
	TABLE 24	ENTERPRISE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 25	NORTH AMERICA: ENTERPRISE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($ MILLION)	
	TABLE 26	SITE CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	TABLE 27	NORTH AMERICA: SITE CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)		
	TABLE 28	CTMS PENETRATION, BY GEOGRAPHY, 2010	
	TABLE 29	NORTH AMERICA: CTMS MARKET REVENUE, BY COUNTRY, 2008 – 2016 ($MILLION)	
	TABLE 30	NORTH AMERICA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)		
	TABLE 31	NORTH AMERICA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)		
	TABLE 32	NORTH AMERICA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)		
	TABLE 33	NORTH AMERICA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)		
	TABLE 34	U.S: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)	
	TABLE 35	U.S: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)	
	TABLE 36	U.S.: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)	
	TABLE 37	U.S: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)	
	TABLE 38	CANADA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)	
	TABLE 39	CANADA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)	
	TABLE 40	CANADA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)	
	TABLE 41	CANADA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)	
	TABLE 42	EUROPE: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)	
	TABLE 43	EUROPE: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)	
	TABLE 44	EUROPE: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)	
	TABLE 45	EUROPE: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)	
	TABLE 46	ASIA: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)	
	TABLE 47	ASIA: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)	
	TABLE 48	ASIA: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)	
	TABLE 49	ASIA: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)	
	TABLE 50	ROW: CTMS MARKET REVENUE, BY END-USERS, 2008 – 2016 ($MILLION)	
	TABLE 51	ROW: CTMS MARKET REVENUE, BY DELIVERY MODE, 2008 – 2016 ($MILLION)	
	TABLE 52	ROW: CTMS MARKET REVENUE, BY COMPONENTS, 2008 – 2016 ($MILLION)	
	TABLE 53	ROW: CTMS MARKET REVENUE, BY CTMS TYPES, 2008 – 2016 ($MILLION)	
	TABLE 54	MARKET SHARE OF HEALTHCARE PROVIDERS IN GLOBAL CLINICAL TRIALS, 1998 – 2007	
	TABLE 55	DRIFT OF NORTH AMERICAN SHARE IN GLOBAL CLINICAL TRIAL, 1990 – 2007		
	TABLE 56	BIOCLINICA INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)	
	TABLE 57	BIOCLINICA INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)	
	TABLE 58	ERESEARCH TECHNOLOGY INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)	
	TABLE 59	ERESEARCH TECHNOLOGY INC: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)		
	TABLE 60	ERESEARCH TECHNOLOGY INC: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)	
	TABLE 61	MEDIDATA SOLUTIONS: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)		
	TABLE 62	MEDIDATA SOLUTIONS: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)	
	TABLE 63	MEDIDATA SOLUTIONS: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)	
	TABLE 64	MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)	
	TABLE 65	MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)	
	TABLE 66	MERGE HEALTHCARE INCORPORATED: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)		
	TABLE 67	OMNICOMM SYSTEMS INC: TOTAL REVENUE AND R&D EXPENSES, 2008 – 2010 ($MILLION)		
	TABLE 68	ORACLE CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)		
	TABLE 69	ORACLE CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)	
	TABLE 70	ORACLE CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)		
	TABLE 71	PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)	
	TABLE 72	PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)		
	TABLE 73	PAREXEL INTERNATIONAL CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)		
	 		

LIST OF FIGURES		
			
	FIGURE 1		PROCESS OF CLINICAL TRIALS	
	FIGURE 2		DRIVERS & RESTRAINTS FOR CTMS MARKET	
	FIGURE 3		MARKET SHARE ANALYSIS, BY COMPETITORS, (BASED ON SOFTWARE LICENSE REVENUE SHARE), 2010	
	FIGURE 4		MODULES OF CTMS	
	FIGURE 5		CTMS MARKET, BY END-USERS, 2010	
	FIGURE 6		CTMS MARKET, BY DELIVERY MODE, 2010 VS. 2016	
	FIGURE 7		CTMS MARKET SHARE, BY COMPONENTS, 2010	
	FIGURE 8		CTMS PENETRATION, BY GEOGRAPHY, 2010 (%)	
	FIGURE 9		CTMS MARKET REVENUE, BY GEOGRAPHY, 2008 – 2016 ($MILLION)	
	FIGURE 10	MARKET SHARE OF HEALTHCARE PROVIDERS IN GLOBAL CLINICAL TRIALS, 1998 VS 2007	
	FIGURE 11	DRIFT OF NORTH AMERICAN SHARE IN GLOBAL CLINICAL TRIAL, 1990 – 2007		
	FIGURE 12	GRANT FUNDED VS. SELF FINANCING TRIALS	
	FIGURE 13	INDUSTRY VS AMC WITH/WITHOUT GRANT VS NIH/U.S. FED ALONE	
	FIGURE 14	INDUSTRY VS. INDUSTRY PLUS AMC	
	FIGURE 15	INDUSTRY VS. AMC VS. U.S. FED PLUS NIH	
	FIGURE 16	INDUSTRY VS. AMC VS. US FED VS. NIH	
	FIGURE 17	KEY GROWTH STRATEGIES, 2008 – 2011